Trial Profile
Open study of clarithromycin for the treatment of infections caused by nontuberculous mycobacteria (NTM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2017
Price :
$35
*
At a glance
- Drugs Clarithromycin (Primary)
- Indications Mycobacterial infections; Mycobacterium avium complex infections; Nontuberculous mycobacterium infections
- Focus Therapeutic Use
- 18 May 2017 Status changed from active, no longer recruiting to completed.
- 29 Feb 2008 New trial record.